Overview
Obatala Sciences provides human-derived hydrogels for 2D and 3D cell culture, organ-on-a-chip models, and adipose tissue engineering tools like the ObaCell platform for research in obesity, diabetes, cancer, and regenerative medicine. Their offerings include customized stem cell isolation services from human or animal tissues and fully humanized microphysiological systems to advance drug development. Based in New Orleans, the company emphasizes diversity in biotechnology research models.
Frequently asked questions
- What are Obatala Sciences' main products for pharma R&D?
- Key offerings include human-derived hydrogels for 2D/3D cell culture, ObaCell obesity-on-a-chip platform, and custom stem cell isolation services such as SVF, ASC, BMSC, and DFC from human or animal tissues.
- What research areas does Obatala Sciences support?
- They focus on obesity, diabetes, cancer, orthopedic conditions, tissue engineering, and regenerative medicine through adipose-derived models and organ-on-a-chip technologies.
- Does Obatala Sciences offer services for diverse human models?
- Yes, their platforms create human cellular tissue models embracing diversity across ethnicity, age, and gender to improve accuracy in drug development research.